abrdn Healthcare Investors operates as a closed-end investment fund, which engages in the investment in the life sciences industry. It invests in biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals and healthcare information technology and services. The company was founded on February 20, 1992 and is headquartered in Boston, MA.
Sector:
Miscellaneous
Industry:
Investment Trusts Or Mutual Funds
Employees:
N/A
Frequently Asked Questions
What is Market Cap of abrdn Life Sciences Investors?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. abrdn Life Sciences Investors market cap is $510.46M.
What is the 52-week high for abrdn Life Sciences Investors?
52 week high is the highest price of a stock in the past 52 weeks, or one year. abrdn Life Sciences Investors 52 week high is $17.69 as of October 29, 2025.
What is the 52-week low for abrdn Life Sciences Investors?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. abrdn Life Sciences Investors 52 week low is $10.55 as of October 29, 2025.
What is abrdn Life Sciences Investors stock price today?
abrdn Life Sciences Investors stock price today is $17.68.
What was abrdn Life Sciences Investors stock price yesterday?
abrdn Life Sciences Investors stock price yesterday was $17.35.
What is the PE ratio of abrdn Life Sciences Investors?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. abrdn Life Sciences Investors’s P/E ratio is -45.65.
What is the Price-to-Book ratio of abrdn Life Sciences Investors?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. abrdn Life Sciences Investors P/B ratio is 1.2892.
What is the 50-day moving average of abrdn Life Sciences Investors?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. abrdn Life Sciences Investors 50-day moving average is $15.04.